These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 33257833)

  • 1. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.
    Trebicka J; Bork P; Krag A; Arumugam M
    Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):167-180. PubMed ID: 33257833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
    Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
    Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiota in cirrhosis and its role in hepatic decompensation.
    Trebicka J; Macnaughtan J; Schnabl B; Shawcross DL; Bajaj JS
    J Hepatol; 2021 Jul; 75 Suppl 1(Suppl 1):S67-S81. PubMed ID: 34039493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers.
    Trebicka J; Hernaez R; Shawcross DL; Gerbes AL
    Gut; 2024 May; 73(6):1015-1024. PubMed ID: 38527788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure.
    Kim SE; Park JW; Kim HS; Jang MK; Suk KT; Kim DJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
    Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
    J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development and features of infection in patients with acute-on-chronic liver failure and its influence on disease progression and prognosis].
    Cao ZJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):6-9. PubMed ID: 29804354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
    Trebicka J; Amoros A; Pitarch C; Titos E; Alcaraz-Quiles J; Schierwagen R; Deulofeu C; Fernandez-Gomez J; Piano S; Caraceni P; Oettl K; Sola E; Laleman W; McNaughtan J; Mookerjee RP; Coenraad MJ; Welzel T; Steib C; Garcia R; Gustot T; Rodriguez Gandia MA; Bañares R; Albillos A; Zeuzem S; Vargas V; Saliba F; Nevens F; Alessandria C; de Gottardi A; Zoller H; Ginès P; Sauerbruch T; Gerbes A; Stauber RE; Bernardi M; Angeli P; Pavesi M; Moreau R; Clària J; Jalan R; Arroyo V
    Front Immunol; 2019; 10():476. PubMed ID: 30941129
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver cirrhosis and immune dysfunction.
    Hasa E; Hartmann P; Schnabl B
    Int Immunol; 2022 Sep; 34(9):455-466. PubMed ID: 35792761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
    Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute-on-chronic liver failure exists in patients with hepatitis B virus-related decompensated cirrhosis.
    Wang SJ; Yin S; Gu WY; Zhang Y; Li H
    J Dig Dis; 2018 Oct; 19(10):614-625. PubMed ID: 30226019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated Adaptive Immunity Is an Early Event in Liver Cirrhosis Preceding Acute-on-Chronic Liver Failure.
    Rueschenbaum S; Ciesek S; Queck A; Widera M; Schwarzkopf K; Brüne B; Welsch C; Wedemeyer H; Zeuzem S; Weigert A; Lange CM
    Front Immunol; 2020; 11():534731. PubMed ID: 33574809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Microbiome in Patients With Cirrhosis and Complications.
    Acharya C; Bajaj JS
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute-on-chronic liver failure in cirrhosis.
    Arroyo V; Moreau R; Kamath PS; Jalan R; Ginès P; Nevens F; Fernández J; To U; García-Tsao G; Schnabl B
    Nat Rev Dis Primers; 2016 Jun; 2():16041. PubMed ID: 27277335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.
    Clària J; Stauber RE; Coenraad MJ; Moreau R; Jalan R; Pavesi M; Amorós À; Titos E; Alcaraz-Quiles J; Oettl K; Morales-Ruiz M; Angeli P; Domenicali M; Alessandria C; Gerbes A; Wendon J; Nevens F; Trebicka J; Laleman W; Saliba F; Welzel TM; Albillos A; Gustot T; Benten D; Durand F; Ginès P; Bernardi M; Arroyo V;
    Hepatology; 2016 Oct; 64(4):1249-64. PubMed ID: 27483394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
    Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute-on-chronic liver failure: a new clinical entity.
    Moreau R; Arroyo V
    Clin Gastroenterol Hepatol; 2015 May; 13(5):836-41. PubMed ID: 24583872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.
    Markwardt D; Holdt L; Steib C; Benesic A; Bendtsen F; Bernardi M; Moreau R; Teupser D; Wendon J; Nevens F; Trebicka J; Garcia E; Pavesi M; Arroyo V; Gerbes AL
    Hepatology; 2017 Oct; 66(4):1232-1241. PubMed ID: 28545169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study.
    Ferreira Cardoso M; Alexandrino G; Carvalho E Branco J; Anapaz V; Carvalho R; Horta D; Martins A
    Gastroenterol Hepatol; 2019 May; 42(5):296-303. PubMed ID: 30772084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.